(VIANEWS) – SiTime Corporation (SITM), Tyler Technologies (TYL), Falcon Minerals Corporation (FLMN) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. SiTime Corporation (SITM)

82.2% sales growth and 6.72% return on equity

SiTime Corporation, a semiconductor company, provides silicon timing systems solutions in Taiwan, Hong Kong, the United States, and internationally.

SiTime Corporation’s sales growth this year is anticipated to be 84.4% and 31.1% for next year.

Year-on-year quarterly revenue growth grew by 92.9%, now sitting on 183.34M for the twelve trailing months.

Volume

Today’s last reported volume for SiTime Corporation is 209070 which is 44.83% below its average volume of 378968.

SiTime Corporation’s sales growth for the next quarter is 82.2%. The company’s growth estimates for the current quarter and the next is 153.5% and 247.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.72%.

Volatility

SiTime Corporation’s last day, last week, and last month’s current intraday variation average was 4.56%, 4.01%, and 3.71%, respectively.

SiTime Corporation’s highest amplitude of average volatility was 6.23% (day), 7.73% (last week), and 7.34% (last month), respectively.

SiTime Corporation’s Stock Yearly Top and Bottom Value

SiTime Corporation’s stock is valued at $239.85 at 10:22 EST, way below its 52-week high of $341.77 and way higher than its 52-week low of $75.81.

SiTime Corporation’s Moving Average

SiTime Corporation’s worth is way under its 50-day moving average of $275.40 and way above its 200-day moving average of $185.19.

2. Tyler Technologies (TYL)

50.2% sales growth and 9.76% return on equity

Tyler Technologies, Inc. provides integrated information management solutions and services for the public sector in the United States and internationally.

Tyler Technologies’s sales growth this year is anticipated to be 38.8% and 18.1% for next year.

Year-on-year quarterly revenue growth grew by 6.6%, now sitting on 1.13B for the twelve trailing months.

Volume

Today’s last reported volume for Tyler Technologies is 275947 which is 59.25% above its average volume of 173269.

Tyler Technologies’s sales growth is a negative 0% for the ongoing quarter and 50.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 18% and 25.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.76%.

Volatility

Tyler Technologies’s last day, last week, and last month’s current intraday variation average was 2.70%, 1.80%, and 1.98%, respectively.

Tyler Technologies’s highest amplitude of average volatility was 6.83% (day), 4.85% (last week), and 3.74% (last month), respectively.

Tyler Technologies’s Stock Yearly Top and Bottom Value

Tyler Technologies’s stock is valued at $466.82 at 10:22 EST, way below its 52-week high of $549.08 and way higher than its 52-week low of $372.80.

Tyler Technologies’s Moving Average

Tyler Technologies’s worth is under its 50-day moving average of $501.58 and higher than its 200-day moving average of $464.56.

3. Falcon Minerals Corporation (FLMN)

45.6% sales growth and 7.64% return on equity

Falcon Minerals Corporation acquires and owns mineral, royalty, and over-riding royalty interests in oil and natural gas properties in North America.

Falcon Minerals Corporation’s sales growth this year is anticipated to be 68.6% and 14.7% for next year.

Year-on-year quarterly revenue growth grew by 103.6%, now sitting on 63.62M for the twelve trailing months.

Volume

Today’s last reported volume for Falcon Minerals Corporation is 548578 which is 15.52% below its average volume of 649372.

Falcon Minerals Corporation’s sales growth for the next quarter is 45.6%. The company’s growth estimates for the ongoing quarter and the next is 700% and 400%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.64%.

Volatility

Falcon Minerals Corporation’s last day, last week, and last month’s current intraday variation average was 0.60%, 3.06%, and 2.46%, respectively.

Falcon Minerals Corporation’s highest amplitude of average volatility was 2.63% (day), 5.53% (last week), and 4.56% (last month), respectively.

Falcon Minerals Corporation’s Stock Yearly Top and Bottom Value

Falcon Minerals Corporation’s stock is valued at $4.98 at 10:22 EST, way under its 52-week high of $6.58 and way above its 52-week low of $3.05.

Falcon Minerals Corporation’s Moving Average

Falcon Minerals Corporation’s worth is under its 50-day moving average of $5.06 and above its 200-day moving average of $4.94.

4. Horizon Therapeutics (HZNP)

27.5% sales growth and 16.1% return on equity

Horizon Therapeutics Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing of medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally.

Horizon Therapeutics’s sales growth this year is anticipated to be 41.2% and 23.5% for next year.

Year-on-year quarterly revenue growth grew by 79.9%, now sitting on 2.56B for the twelve trailing months.

Volume

Today’s last reported volume for Horizon Therapeutics is 1910250 which is 17.79% above its average volume of 1621640.

Horizon Therapeutics’s sales growth for the next quarter is 27.5%. The company’s growth estimates for the present quarter and the next is a negative 11.5% and 10.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.1%.

Volatility

Horizon Therapeutics’s last day, last week, and last month’s current intraday variation average was 0.50%, 1.17%, and 1.60%, respectively.

Horizon Therapeutics’s highest amplitude of average volatility was 4.11% (day), 3.97% (last week), and 3.97% (last month), respectively.

Horizon Therapeutics’s Stock Yearly Top and Bottom Value

Horizon Therapeutics’s stock is valued at $86.85 at 10:22 EST, way below its 52-week high of $120.54 and way higher than its 52-week low of $66.41.

Horizon Therapeutics’s Moving Average

Horizon Therapeutics’s worth is way under its 50-day moving average of $109.80 and way under its 200-day moving average of $100.05.

Previous days news about Horizon Therapeutics(HZNP)

  • According to Benzinga on Monday, 24 January, "Paul W. Hoelscher, Executive Vice President, Chief Financial Officer of Horizon Therapeutics plc, has been appointed to the Board and will serve as chair of the Audit Committee. ", "Mr. Hoelscher currently serves as Executive Vice President, Chief Financial Officer of Horizon Therapeutics plc, a biotech company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. "

5. Universal Display Corporation (OLED)

10.5% sales growth and 20.07% return on equity

Universal Display Corporation engages in the research, development, and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications.

Universal Display Corporation’s sales growth this year is expected to be 28.4% and 22.4% for next year.

Year-on-year quarterly revenue growth grew by 22.7%, now sitting on 548.82M for the twelve trailing months.

Volume

Today’s last reported volume for Universal Display Corporation is 429594 which is 5.63% below its average volume of 455266.

Universal Display Corporation’s sales growth for the next quarter is 10.5%. The company’s growth estimates for the current quarter and the next is a negative 12.4% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.07%.

Volatility

Universal Display Corporation’s last day, last week, and last month’s current intraday variation average was 3.71%, 3.23%, and 2.11%, respectively.

Universal Display Corporation’s highest amplitude of average volatility was 4.02% (day), 5.08% (last week), and 3.82% (last month), respectively.

Universal Display Corporation’s Stock Yearly Top and Bottom Value

Universal Display Corporation’s stock is valued at $158.85 at 10:22 EST, way under its 52-week high of $262.77 and way above its 52-week low of $139.83.

Universal Display Corporation’s Moving Average

Universal Display Corporation’s worth is under its 50-day moving average of $161.93 and way under its 200-day moving average of $196.90.

LEAVE A REPLY

Please enter your comment!
Please enter your name here